Isorhamnetin glucoside

Isorhamnetin glucoside is a methylated flavonol glycoside that provides antioxidant activity through free radical scavenging mechanisms. This compound undergoes intestinal metabolism to produce bioactive metabolites including kaempferol and quercetin.

Category: Compound Evidence: 4/10 Tier: Preliminary (in-vitro/animal)
Isorhamnetin glucoside — Hermetica Encyclopedia

Origin & History

Isorhamnetin glucoside is a glycosylated flavonoid compound found naturally in plants, consisting of the aglycone isorhamnetin (a methylated derivative of quercetin) attached to a glucose molecule at position 7. Related forms like isorhamnetin 3-O-glucoside are found in vegetables and rice, typically extracted using ultraperformance liquid chromatography methods.

Historical & Cultural Context

No historical or traditional medicine uses are documented for isorhamnetin glucoside. The compound has only been studied in modern laboratory settings.

Health Benefits

• Antioxidant properties noted in research, though only in vitro evidence available
• Potential gut microbiome modulation through bacterial fermentation (preliminary evidence from in vitro studies)
• May yield beneficial metabolites like kaempferol and quercetin after intestinal metabolism (in vitro data only)
• Possible role in flavonoid biosynthesis pathways (mechanistic studies only)
• No human clinical trials available to confirm any health benefits

How It Works

Isorhamnetin glucoside exerts antioxidant effects by donating electrons to neutralize reactive oxygen species and chelating metal ions that catalyze oxidative reactions. Upon ingestion, intestinal β-glucosidases cleave the glucose moiety, releasing isorhamnetin which can be further demethylated to produce kaempferol and quercetin. These metabolites interact with cellular antioxidant pathways including Nrf2 activation and modulation of gut microbiota composition through selective bacterial fermentation.

Scientific Research

No human clinical trials, RCTs, or meta-analyses specifically on isorhamnetin glucoside have been conducted. Current research is limited to in vitro metabolism studies examining bacterial fermentation by intestinal microbiota, without any published PMIDs or clinical outcome data.

Clinical Summary

Current research on isorhamnetin glucoside is limited to in vitro laboratory studies examining its antioxidant capacity and metabolic fate. Cell culture studies have demonstrated free radical scavenging activity, though specific IC50 values and direct cellular protective effects require further investigation. Preliminary in vitro fermentation studies suggest potential prebiotic effects through selective bacterial metabolism, but no human clinical trials have been conducted. The evidence base remains insufficient to establish definitive therapeutic benefits or optimal dosing protocols.

Nutritional Profile

Isorhamnetin glucoside (isorhamnetin-3-O-glucoside, molecular weight ~478.4 g/mol) is a methylated flavonol glycoside — the 3'-O-methyl derivative of quercetin bound to glucose at the 3-position. It is not a macronutrient source and contains no significant vitamins, minerals, fiber, or protein. Found in foods such as sea buckthorn berries (50–200 mg/kg dry weight), onion skins, ginkgo leaves, and certain Brassica vegetables at low concentrations (typically 1–30 mg per serving depending on source). As a glycoside, it has limited direct intestinal absorption; bioavailability is low (~2–5% intact absorption estimated from flavonol glycoside studies). The glucose moiety is cleaved by intestinal β-glucosidases and lactase-phlorizin hydrolase, releasing free isorhamnetin aglycone. A substantial fraction (~70–80%) passes to the colon where gut microbiota further degrade it into smaller phenolic acids (3,4-dimethoxyphenylacetic acid, 3-hydroxyphenylacetic acid) and potentially regenerate quercetin/kaempferol via demethylation. Hepatic phase II metabolism produces glucuronide and sulfate conjugates, which are the predominant circulating forms with plasma half-life estimated at 2–5 hours.

Preparation & Dosage

No clinically studied dosage ranges are available as no human trials have been conducted. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Pairs well with **quercetin** (500 mg), **vitamin C** (250–500 mg), **piperine** (5–10 mg from black pepper extract), and **rutin** (250 mg). Quercetin and isorhamnetin share overlapping yet complementary antioxidant mechanisms — quercetin's catechol B-ring and isorhamnetin's methylated B-ring target different reactive oxygen species and may additively inhibit NF-κB and xanthine oxidase pathways. Vitamin C regenerates oxidized flavonol radicals back to their active reduced forms, extending their antioxidant cycling capacity, while also stabilizing these flavonoids in the gut lumen. Piperine inhibits hepatic UDP-glucuronosyltransferase and CYP3A4 enzymes, significantly slowing phase II conjugation and first-pass metabolism of isorhamnetin aglycone, thereby increasing its plasma bioavailability by an estimated 30–50%. Rutin (quercetin-3-O-rutinoside) provides a slower-release colonic source of quercetin via microbial rhamnosidase activity, creating a sustained complementary flavonol presence alongside isorhamnetin glucoside's earlier small-intestinal release.

Safety & Interactions

No specific safety data exists for isorhamnetin glucoside as an isolated compound, though it is generally consumed as part of flavonoid-rich foods without reported adverse effects. Theoretical interactions may occur with medications metabolized by cytochrome P450 enzymes, similar to other flavonoids, though clinical significance remains unknown. Pregnant and breastfeeding women should avoid supplemental forms due to lack of safety data. Individuals with known flavonoid sensitivities should exercise caution when consuming concentrated sources.